Dr. Gilbert on Precision Medicine in Glioblastoma

Video

Mark R. Gilbert, MD, senior investigator, chief, Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, discusses the use of precision medicine in treating patients with glioblastoma.

Mark R. Gilbert, MD, senior investigator, chief, Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, discusses the use of precision medicine in treating patients with glioblastoma.

Gilbert explains that there are complications in the various components of precision medicine and by breaking them down, there may be a greater understanding in treating these patients. These components include tumor heterogeneity, he adds.

Research conducted within The Cancer Genome Atlas has shown that there is differentiation within various cells of one tumor. Therefore, making informed treatment decisions based on original diagnostic tissue should not be done, Gilbert says.

<<<

View more from the 2015 SNO Meeting

Related Videos
Arya Amini, MD
Patrick I. Borgen, MD
Adrianna Masters, MD, PhD,
Kari Hacker, MD, PhD, NYU Grossman School of Medicine
Janos L. Tanyi, MD, PhD, associate professor, Obstetrics and Gynecology, Hospital of the University of Pennsylvania
Reshma Lillaney Mahtani, DO
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology